Clinical Trials in Arizona

Showing 1381-1400 of 8,032 trials

Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities

NCT05447923

This clinical trial studies disparities involving colorectal cancer prevention and screening in Black and underserved communities in the Phoenix metropolitan area. The Black community is disproportionately impacted by colorectal cancer, with the highest rate of any racial/ethnic group in the United States. There are complex reasons behind these disparities, largely related to socioeconomic factors and healthcare access. Providing access to free, home-based fecal immunochemical testing (FIT), colorectal screening education, and appropriate follow-up to predominantly Black community-based organizations and underserved communities may help to close this gap.

Colorectal Carcinoma

Mayo Clinic450 participantsStarted May 2022

Scottsdale, Arizona, United States

COMPLETEDPhase 231 miles

Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2)

NCT05103332

The purpose of this study is to evaluate the effect of zilebesiran on systolic and diastolic blood pressure and to characterize the pharmacodynamic (PD) effects and safety of zilebesiran as add-on therapy.

Hypertension

Alnylam Pharmaceuticals663 participantsStarted Nov 2021

Mesa, Arizona, United States • Tempe, Arizona, United States • Tempe, Arizona, United States +107 more locations

Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities

Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2)

Find Trials by Condition in Arizona

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema

Combining a Smartphone App With Medications to Manage Heavy Drinking

Study of Posterior Cervical Stabilization System (PCSS) as Part of Circumferential Fusion to Treat Multilevel DDD

ZILRETTA in Subjects With Shoulder Osteoarthritis

Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery

FebriDx® Pediatric Validation Study

To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate

New Treatment for Alcohol and Nicotine Dependence

A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With Cold Agglutinin Disease (CAD)

OCS Heart Perfusion Post-Approval Registry

Study of Intratumoral (IT) Ulevostinag (MK-1454) in Combination With Intravenous (IV) Pembrolizumab (MK-3475) Compared to IV Pembrolizumab Alone as the First Line Treatment of Metastatic or Unresectable, Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) (MK-1454-002)

Safety Study of Adenovirus Vector Engineered to Express hIL-12 in Combination With Activator Ligand to Treat Melanoma

Comparing Surgical and Endovascular Arteriovenous Fistula Creation

Study of Ulevostinag (MK-1454) Alone or in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors or Lymphomas (MK-1454-001)

Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1

Clinical Validation Study of the Eximis CS (Contained Segmentation) System

SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST

Evaluate the Safety and Effectiveness of the Polymotion Hip Resurfacing (PHR) System Compared to Total Hip Arthroplasty